Amazon cover image
Image from Amazon.com

Contraceptive risk : the FDA, Depo-Provera, and the politics of experimental medicine / William Green.

By: Material type: TextTextPublisher: New York : New York University, [2017]Description: 1 online resourceContent type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9781479825929
  • 1479825921
Subject(s): Genre/Form: Additional physical formats: Print version:: Contraceptive risk.DDC classification:
  • 618.1/8 23
LOC classification:
  • RG136 .G67 2017eb
NLM classification:
  • WP 630
Online resources:
Contents:
Introduction : the odyssey of Depo-Provera -- The Grady Hospital study : the corruption of contraceptive research -- The twenty-five-year FDA approval controversy : cancer and the politics of acceptable risk -- Contraceptive chaos : unapproved use and Upjohn v. MacMurdo -- Marketing approval and litigation : osteoporosis and the realities of medical risk -- Chemical castration : the John Hopkins Clinic and People v. Gauntlett -- Conclusions : contraceptive drug risk failure, human dignity, and a duty to act.
Summary: Depo-Provera is known as an injectable hormonal birth control method, but few are familiar with its dark and complicated history. Depo-Provera was tested on women since the mid-1960s without their informed consent until it was FDA-approved in 1992, but never FDA-approved as chemical castration for male sex offenders. Contraceptive risk is the author's landmark study of Depo-Provera. Based on a fascinating combination of archival materials and interviews, the book is framed as three interconnected stories told by Judith Weisz, who chaired the FDA's Public Board of Inquiry on Depo-Provera, a scientific court; by Anne MacMurdo who brought a products liability suit against Upjohn, the drug's manufacturer, for the deleterious side effects she suffered from the drug's use; and by Roger Gauntlett, an Upjohn heir who, when he was convicted of sexual assault, refused to take a dose of his family's own medicine as a probation condition. Together these three stories of Depo-Provera's convoluted fifty year odyssey call for a paradigm shift in pharmaceutical drug development. Contraceptive risk is a thoroughly researched and engrossing approach to the scientific, political and institutional forces involved in health law and policy, as well as the multifaceted politics of measuring risk.--description from back cover.
Item type:
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Home library Collection Call number Materials specified Status Date due Barcode
Electronic-Books Electronic-Books OPJGU Sonepat- Campus E-Books EBSCO Available

Includes bibliographical references and index.

Print version record.

Introduction : the odyssey of Depo-Provera -- The Grady Hospital study : the corruption of contraceptive research -- The twenty-five-year FDA approval controversy : cancer and the politics of acceptable risk -- Contraceptive chaos : unapproved use and Upjohn v. MacMurdo -- Marketing approval and litigation : osteoporosis and the realities of medical risk -- Chemical castration : the John Hopkins Clinic and People v. Gauntlett -- Conclusions : contraceptive drug risk failure, human dignity, and a duty to act.

Depo-Provera is known as an injectable hormonal birth control method, but few are familiar with its dark and complicated history. Depo-Provera was tested on women since the mid-1960s without their informed consent until it was FDA-approved in 1992, but never FDA-approved as chemical castration for male sex offenders. Contraceptive risk is the author's landmark study of Depo-Provera. Based on a fascinating combination of archival materials and interviews, the book is framed as three interconnected stories told by Judith Weisz, who chaired the FDA's Public Board of Inquiry on Depo-Provera, a scientific court; by Anne MacMurdo who brought a products liability suit against Upjohn, the drug's manufacturer, for the deleterious side effects she suffered from the drug's use; and by Roger Gauntlett, an Upjohn heir who, when he was convicted of sexual assault, refused to take a dose of his family's own medicine as a probation condition. Together these three stories of Depo-Provera's convoluted fifty year odyssey call for a paradigm shift in pharmaceutical drug development. Contraceptive risk is a thoroughly researched and engrossing approach to the scientific, political and institutional forces involved in health law and policy, as well as the multifaceted politics of measuring risk.--description from back cover.

eBooks on EBSCOhost EBSCO eBook Subscription Academic Collection - Worldwide

There are no comments on this title.

to post a comment.

O.P. Jindal Global University, Sonepat-Narela Road, Sonepat, Haryana (India) - 131001

Send your feedback to glus@jgu.edu.in

Hosted, Implemented & Customized by: BestBookBuddies   |   Maintained by: Global Library